VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
PHASE2CompletedINTERVENTIONAL
Enrollment
22
Participants
Timeline
Start Date
November 30, 2006
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2014
Conditions
Adenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral CancerRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerSquamous Cell Carcinoma of the BladderStage III Bladder CancerStage III Urethral CancerStage IV Bladder CancerTransitional Cell Carcinoma of the BladderUrethral Cancer Associated With Invasive Bladder Cancer
Interventions
BIOLOGICAL
ziv-aflibercept
Given IV
OTHER
pharmacological study
Correlative studies
Trial Locations (1)
91010
City of Hope, Duarte
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00407485 - VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium | Biotech Hunter | Biotech Hunter